The Biotech Growth Trust PLC Market Cap ($3.41 Million)
Market Cap & Net Worth: The Biotech Growth Trust PLC (BIOG)
The Biotech Growth Trust PLC market cap. The Biotech Growth Trust PLC (LSE:BIOG) has a market capitalization of $3.41 Million (GBX28.05 Billion) as of November 3, 2026. Listed on the LSE stock exchange, this UK-based company holds position #29236 globally and #563 in its home market, demonstrating a 0.75% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying The Biotech Growth Trust PLC's stock price GBX1352.00 by its total outstanding shares 20747975 (20.75 Million). Also see The Biotech Growth Trust PLC (BIOG) cash flow conversion for how efficiently the company converts equity into cash flow.
The Biotech Growth Trust PLC Market Cap History (2015–2026)
The Biotech Growth Trust PLC market cap history from 2015 to 2026. Data shows growth from $1.87 Million to $3.41 Million (6.87% CAGR). Check BIOG live share price for real-time trading data and today's change.
Index Memberships
The Biotech Growth Trust PLC is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
FTSE All-Share
FTAS
|
$67.31 Billion | 0.01% | #394 of 573 |
Weight: The Biotech Growth Trust PLC's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
The Biotech Growth Trust PLC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how The Biotech Growth Trust PLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of The Biotech Growth Trust PLC to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
-0.04x
The Biotech Growth Trust PLC's market cap is -0.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.78 Million | $-126.69 Million | -$128.95 Million | -0.01x | N/A |
| 2017 | $1.99 Million | $100.47 Million | $98.30 Million | 0.02x | 0.02x |
| 2018 | $1.60 Million | $-27.51 Million | -$29.78 Million | -0.06x | N/A |
| 2019 | $2.37 Million | $23.05 Million | $21.10 Million | 0.10x | 0.11x |
| 2020 | $3.98 Million | $63.89 Million | $60.90 Million | 0.06x | 0.07x |
| 2021 | $3.00 Million | $204.35 Million | $200.43 Million | 0.01x | 0.01x |
| 2022 | $2.34 Million | $-209.71 Million | -$202.42 Million | -0.01x | N/A |
| 2023 | $2.26 Million | $-37.65 Million | -$41.30 Million | -0.06x | N/A |
| 2024 | $2.16 Million | $80.35 Million | $74.60 Million | 0.03x | 0.03x |
| 2025 | $3.03 Million | $-77.48 Million | -$82.66 Million | -0.04x | N/A |
Competitor Companies of BIOG by Market Capitalization
Companies near The Biotech Growth Trust PLC in the global market cap rankings as of November 3, 2026. Also see how large is The Biotech Growth Trust PLC's balance sheet for a full breakdown of the balance sheet.
Key companies related to The Biotech Growth Trust PLC by market ranking:
- BlackRock Inc (NYSE:BLK): Ranked #134 globally with a market cap of $167.86 Billion USD.
- Brookfield Corporation (TO:BN): Ranked #275 globally with a market cap of $94.09 Billion USD ( CA$130.07 Billion CAD).
- Blackstone Group Inc (NYSE:BX): Ranked #288 globally with a market cap of $90.42 Billion USD.
- KKR & Co. Inc. (NYSE:KKR): Ranked #303 globally with a market cap of $87.98 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #134 | BlackRock Inc | NYSE:BLK | $167.86 Billion | $1167.15 |
| #275 | Brookfield Corporation | TO:BN | $94.09 Billion | CA$57.95 |
| #288 | Blackstone Group Inc | NYSE:BX | $90.42 Billion | $120.14 |
| #303 | KKR & Co. Inc. | NYSE:KKR | $87.98 Billion | $98.01 |
Market Capitalization of The Biotech Growth Trust PLC (2015–2026)
Market capitalization of The Biotech Growth Trust PLC from 2015 to today. Between 2015 and today, The Biotech Growth Trust PLC's market cap moved from $1.87 Million to $ 3.41 Million, with a yearly change of 6.87%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | GBX3.41 Million | +12.67% |
| 2025 | GBX3.03 Million | +40.35% |
| 2024 | GBX2.16 Million | -4.36% |
| 2023 | GBX2.26 Million | -3.46% |
| 2022 | GBX2.34 Million | -22.05% |
| 2021 | GBX3.00 Million | -24.62% |
| 2020 | GBX3.98 Million | +67.66% |
| 2019 | GBX2.37 Million | +48.50% |
| 2018 | GBX1.60 Million | -19.87% |
| 2017 | GBX1.99 Million | +12.06% |
| 2016 | GBX1.78 Million | -4.73% |
| 2015 | GBX1.87 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of The Biotech Growth Trust PLC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.41 Million USD |
| MoneyControl | $3.41 Million USD |
| MarketWatch | $3.41 Million USD |
| marketcap.company | $3.41 Million USD |
| Reuters | $3.41 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About The Biotech Growth Trust PLC
The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create … Read more